Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Amentia

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Amentia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, TC; Holman, BL; Royal, HD1

Reviews

1 review(s) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Amentia

ArticleYear
Clinical brain imaging with isopropyl-iodoamphetamine and SPECT.
    Seminars in nuclear medicine, 1985, Volume: 15, Issue:4

    Topics: Amphetamines; Animals; Brain; Cerebrovascular Disorders; Dementia; Epilepsy; Humans; Iodine Radioisotopes; Iodobenzenes; Iofetamine; Radiation Dosage; Tissue Distribution; Tomography, Emission-Computed

1985